World's Best Scientists 2026 revealed!
Elisabetta Bugianesi

Elisabetta Bugianesi

D-Index & Metrics

Medicine

D-Index
102
Citations
58688
World Ranking
7505
National Ranking
250

Overview

Elisabetta Bugianesi is affiliated with the University of Turin in Italy and has contributed extensively to the field of medicine, with a strong focus on liver-related research. Their work spans several subfields, including epidemiology, hepatology, endocrinology, diabetes and metabolism, physiology, and surgery.

Their research topics primarily cover:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Diet and metabolism studies
  • Hepatitis C virus research
  • Hepatocellular Carcinoma Treatment and Prognosis

Bugianesi's recent papers reflect significant contributions to understanding metabolic dysfunction-associated fatty liver disease and related conditions. Notable recent publications include:

  • "A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement" (2020, Journal of Hepatology)
  • "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease" (2020, Gastroenterology)
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature" (2023, Hepatology)
  • "A multisociety Delphi consensus statement on new fatty liver disease nomenclature" (2023, Journal of Hepatology)
  • "NASH limits anti-tumour surveillance in immunotherapy-treated HCC" (2021, Nature)

Bugianesi collaborates frequently with several co-authors, including:

  • Angelo Armandi
  • Chiara Rosso
  • Salvatore Petta
  • Gian Paolo Caviglia
  • Manuel Romero-Gómez

Their work has been published predominantly in the following venues:

  • Journal of Hepatology
  • Digestive and Liver Disease
  • Clinical Gastroenterology and Hepatology
  • Hepatology
  • Journal of Clinical Medicine

Best Publications

  • Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

    Zobair Younossi;Quentin M. Anstee;Milena Marietti;Timothy Hardy;Timothy Hardy

  • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

    Giulio Marchesini;Elisabetta Bugianesi;Gabriele Forlani;Fernanda Cerrelli

  • Nonalcoholic fatty liver disease a feature of the metabolic syndrome

    Giulio Marchesini;Mara Brizi;Giampaolo Bianchi;Sara Tomassetti

  • A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

    Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee

  • Association of nonalcoholic fatty liver disease with insulin resistance

    Giulio Marchesini;Mara Brizi;Antonio M Morselli-Labate;Giampaolo Bianchi

  • Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

    Elisabetta Bugianesi;Nicola Leone;Ester Vanni;Giulio Marchesini

  • Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

    Zobair Younossi;Zobair Younossi;Frank Tacke;Marco Arrese;Barjesh Chander Sharma

  • NASH limits anti-tumour surveillance in immunotherapy-treated HCC

    Dominik Pfister;Dominik Pfister;Nicolás Gonzalo Núñez;Roser Pinyol;Olivier Govaere

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Insulin resistance: A metabolic pathway to chronic liver disease†

    Elisabetta Bugianesi;Arthur J. McCullough;Giulio Marchesini

  • A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

    Elisabetta Bugianesi;Elena Gentilcore;Rita Manini;Stefania Natale

  • Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease

    Melania Gaggini;Mariangela Morelli;Emma Buzzigoli;Ralph A. DeFronzo

  • Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

    Anna Ludovica Fracanzani;Luca Valenti;Elisabetta Bugianesi;Marco Andreoletti

  • Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

    Nicola Villanova;Simona Moscatiello;Stefano Ramilli;Elisabetta Bugianesi

  • Nonalcoholic fatty liver disease

    Elizabeth M. Brunt;Vincent W.-S. Wong;Valerio Nobili;Christopher P. Day

  • Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.

    Andrea Marengo;Chiara Rosso;Elisabetta Bugianesi

  • Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

    Zobair Younossi;Maria Stepanova;Janus P. Ong;Ira M. Jacobson

  • Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    Stuart McPherson;Stuart McPherson;Tim Hardy;Tim Hardy;Jean-Francois Dufour;Salvatore Petta

  • Homozygosity for the patatin-like phospholipase-3/adiponutrin i148m polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease

    Luca Valenti;Ahmad Al-Serri;Ann K. Daly;Enrico Galmozzi

  • From the metabolic syndrome to NAFLD or vice versa

    Ester Vanni;Elisabetta Bugianesi;Anna Kotronen;Samuele De Minicis

Frequent Co-Authors

Giulio Marchesini
Giulio Marchesini University of Bologna
Amalia Gastaldelli
Amalia Gastaldelli National Research Council (CNR)
Luca Valenti
Luca Valenti University of Milan
Mario Rizzetto
Mario Rizzetto University of Turin
Quentin M. Anstee
Quentin M. Anstee Newcastle University
Jacob George
Jacob George University of Sydney
Salvatore Petta
Salvatore Petta University of Palermo
Silvia Fargion
Silvia Fargion University of Milan
Manuel Romero-Gómez
Manuel Romero-Gómez University of Seville
Maurizio Cassader
Maurizio Cassader University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can unlock a wide range of rewarding healthcare careers. Many students also consider advancing their expertise or opening new pathways with related online programs. Whether you're aiming to practice or lead, online degrees offer valuable flexibility and affordability.

Practicing nurses seeking specialization may explore the shortest post master's pmhnp online programs to quickly gain credentials in psychiatric mental health. For those interested in the business side of healthcare, pursuing an affordable healthcare administration degree online can open doors to leadership positions.

If you’re planning to advance into higher management roles, a cheapest online mha (Master’s in Healthcare Administration) could help you balance costs while growing your expertise. Similarly, those wanting a clinical doctorate can consider a cheap online dnp programs to reach the highest level of nursing practice.

Each of these online programs enables you to enhance your credentials, specialize, or pivot your career—often at your own pace and budget.

Best Scientists Citing Elisabetta Bugianesi

Trending Scientists

Recently Published Articles